Menu
Recruiting NCT07393841

Molecular Indicators of Systematic Fitness

Observational Healthy Adult Fitness Testing Athlete Aging

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: There is no intervention..
Who it may be relevant to
Registry conditions: Healthy Adult, Fitness Testing, Athlete, Aging. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this study is to characterize associations between cardiorespiratory fitness, as measured by VO₂max/VO₂peak, and blood-based molecular measurements in adults. This is an observational study where research staff measures VO₂max/VO₂peak and collects fasted, resting blood samples on the same day. The main questions it aims to answer are: 1. Can a multi-analyte blood panel accurately predict directly measured VO₂max/VO₂peak? 2. How do these blood-based features vary across age, sex, and self-reported or documented physical activity profiles? 3. Are the predictor analytes able to capture changes in VO₂max/VO₂peak caused by a self-directed intervention (e.g., training for a marathon)? 4. What is the analytic reliability of the predictor biomarkers?

Detailed description

Prospective observational cohort with baseline cross-sectional assessment; optional longitudinal follow-up with repeat VO₂max and blood collection in a subset. No intervention is assigned by the investigators. The investigators are amassing a large dataset of diverse individuals with directly measured VO2max paired with blood samples to support robust biomarker development.

Interventions

  • Other There is no intervention.
    The investigators are not administering an intervention for this study. To opportunistically capture prospective data, the investigators give participants the option for re-testing after a period of time where participants are undergoing a self-directed intervention (i.e., no influence of the research staff), such as training for a marathon or other fitness event.

Primary outcome measures

  • A multi-analyte biomarker panel to predict maximal aerobic capacity [Time frame: Day 1]
  • The change in VO2max/VO2peak and a multi-analyte biomarker panel after a self-directed training program. [Time frame: From day 1 through study completion, average of 3 months]

Eligibility criteria

Inclusion criteria

  • Be ≥18 years old
  • Be able to understand and provide informed consent (English; additional languages may be added via amendment with translated materials)
  • Be willing to complete VO₂max testing, blood draw, and questionnaires.
  • Be able to safely perform maximal/symptom-limited exercise testing as determined by: PAR-Q+ screening and investigator review (included as an attachment) and resting vitals screening (heart rate)

Exclusion criteria

  • Conditions that, in the investigator's judgment, or a medical doctor, makes maximal exercise testing unsafe (e.g., unstable cardiovascular symptoms)
  • Contraindications or unwillingness to undergo venipuncture
  • Acute illness (fever, significant respiratory illness) at the time of testing
  • Failure to comply with procedures.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • VO Health, Inc. — New Haven

Identifiers

NCT: NCT07393841 · 9554ed94-872a-4b5c-8a42-13e51f

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗